Your search returned 15 results.

Results
	1.	Effect of extracellular ATP on cisplatin-induced cytotoxicity in human ovarian carcinoma cells. [electronic resource] by Rotte, Anand Garmann, Dirk Buss, Irina Jaehde, Ulrich Producer: 20100708 In: Chemotherapy vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugs. [electronic resource] by Warnecke, André Fichtner, Iduna Garmann, Dirk Jaehde, Ulrich Kratz, Felix Producer: 20050406 In: Bioconjugate chemistry vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration Routes. [electronic resource] by Reinecke, Isabel Hofmann, Birte Mesic, Emir Drenth, Henk-Jan Garmann, Dirk Producer: 20191031 In: Journal of clinical pharmacology vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells. [electronic resource] by Garmann, Dirk Warnecke, André Kalayda, Ganna V Kratz, Felix Jaehde, Ulrich Producer: 20090115 In: Journal of controlled release : official journal of the Controlled Release Society vol. 131 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach. [electronic resource] by Solms, Alexander Iorio, Alfonso Ahsman, Maurice J Vis, Peter Shah, Anita Berntorp, Erik Garmann, Dirk Producer: 20210920 In: Clinical pharmacokinetics vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A. [electronic resource] by Shah, Anita Solms, Alexander Garmann, Dirk Katterle, Yvonne Avramova, Verzhiniya Simeonov, Stanislav Lissitchkov, Toshko Producer: 20180713 In: Clinical pharmacokinetics vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII. [electronic resource] by Abrantes, João A Solms, Alexander Garmann, Dirk Nielsen, Elisabet I Jönsson, Siv Karlsson, Mats O Producer: 20200826 In: CPT: pharmacometrics & systems pharmacology vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients. [electronic resource] by Abrantes, João A Solms, Alexander Garmann, Dirk Nielsen, Elisabet I Jönsson, Siv Karlsson, Mats O Producer: 20210427 In: Haematologica vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations. [electronic resource] by Willmann, Stefan Zhang, Liping Frede, Matthias Kubitza, Dagmar Mueck, Wolfgang Schmidt, Stephan Solms, Alexander Yan, Xiaoyu Garmann, Dirk Producer: 20190827 In: CPT: pharmacometrics & systems pharmacology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes? [electronic resource] by Buss, Irina Garmann, Dirk Galanski, Mathea S Weber, Günther Kalayda, Ganna V Keppler, Bernhard K Jaehde, Ulrich Producer: 20110826 In: Journal of inorganic biochemistry vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Population Pharmacokinetic and Exposure-Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease. [electronic resource] by Snelder, Nelleke Heinig, Roland Drenth, Henk-Jan Joseph, Amer Kolkhof, Peter Lippert, Jörg Garmann, Dirk Ploeger, Bart Eissing, Thomas Producer: 20210526 In: Clinical pharmacokinetics vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling. [electronic resource] by Solms, Alexander Frede, Matthias Berkowitz, Scott D Hermanowski-Vosatka, Anne Kubitza, Dagmar Mueck, Wolfgang Spiro, Theodore E Willmann, Stefan Yan, Xiaoyu Zhang, Liping Garmann, Dirk Producer: 20200819 In: CPT: pharmacometrics & systems pharmacology vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism. [electronic resource] by Solms, Alexander Willmann, Stefan Reinecke, Isabel Spiro, Theodore E Peters, Gary Weitz, Jeffrey I Mueck, Wolfgang Garmann, Dirk Schmidt, Stephan Zhang, Liping Fox, Keith A A Berkowitz, Scott D Producer: 20210409 In: Journal of thrombosis and thrombolysis vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome. [electronic resource] by Zhang, Liping Yan, Xiaoyu Nandy, Partha Willmann, Stefan Fox, Keith A A Berkowitz, Scott D Sharma, Amarnath Hermanowski-Vosatka, Anne Schmidt, Stephan Weitz, Jeffrey I Garmann, Dirk Peters, Gary Producer: 20190813 In: Therapeutic advances in cardiovascular disease vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism. [electronic resource] by Reinecke, Isabel Solms, Alexander Willmann, Stefan Spiro, Theodore E Peters, Gary Weitz, Jeffrey I Mueck, Wolfgang Garmann, Dirk Schmidt, Stephan Zhang, Liping Fox, Keith A A Berkowitz, Scott D Producer: 20210409 In: Journal of thrombosis and thrombolysis vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)